You just read:

aTyr Pharma Reports Promising Signals of Clinical Activity in Multiple Rare Genetically Distinct Myopathies with Resolaris™ in Exploratory Trials

News provided by

aTyr Pharma, Inc.

13 Dec, 2016, 07:00 ET